Integrating these precise functional and quantitative data with the spatial context provided by IHC will be crucial to fully decode the extent to which VEGF-specific immunity counteracts the immunosuppressive tumor milieu and to identify candidate biomarkers of treatment response. Here, VEGFA is linked to neoplasm.